Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Revelation Biosciences, Inc. - Common Stock
(NQ:
REVB
)
1.255
+0.025 (+2.06%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Mar 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Revelation Biosciences, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Revelation Biosciences, Inc. Announces Financial Results For the Three and Twelve Months Ended December 31, 2025
February 26, 2026
Via
ACCESS Newswire
The trading volume of these stocks is deviating from the norm in today's session.
↗
January 26, 2026
Via
Chartmill
REVB Stock Drops 10% After Company Announces Third Reverse Split In A Year
↗
January 26, 2026
Revelation Biosciences said its 1-for-4 reverse stock split will become effective from January 28, 2026.
Via
Stocktwits
American Lithium Minerals (OTC: AMLM) Accelerates Global Expansion Across Gold, Silver, Copper, Critical Minerals, and Rare Earth Elements
January 26, 2026
Via
AB Newswire
Revelation Biosciences Stock Slides 17% After Company Reports 3 Severe Adverse Events In Early Stage Trial Of Inflammation Drug
↗
September 09, 2025
Via
Stocktwits
What's going on in today's session
↗
January 23, 2026
Via
Chartmill
In today's session, these stocks are experiencing unusual volume.
↗
January 23, 2026
Via
Chartmill
Which stocks are moving on Friday?
↗
January 23, 2026
Via
Chartmill
These stocks that are showing activity before the opening bell on Friday.
↗
January 23, 2026
Via
Chartmill
Thursday's session: top gainers and losers
↗
January 22, 2026
Via
Chartmill
Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI
January 21, 2026
Via
ACCESS Newswire
Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026)
January 14, 2026
Via
ACCESS Newswire
Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 12, 2026
Via
ACCESS Newswire
Revelation Biosciences Announces Initiation of GMP Manufacturing of GEMINI and Placebo to Support Later Stage Clinical Development
January 07, 2026
Via
ACCESS Newswire
Revelation Biosciences Has Reached A Quorum For Its December 3, 2025 Special Meeting
December 01, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
November 20, 2025
Via
Benzinga
Revelation Biosciences On Track for End-of-Phase 1 Meeting With FDA Later This Year
November 20, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Monday's After-Market Session
↗
November 10, 2025
Via
Benzinga
REVELATION BIOSCIENCES INC (NASDAQ:REVB) Reports Q3 2025 Loss, Announces Groundbreaking Clinical Data and Improved Cash Runway
↗
November 06, 2025
Revelation Biosciences posts wider Q3 loss but secures funding, extends cash runway into 2026 following positive Gemini study data.
Via
Chartmill
Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2025
November 06, 2025
Via
ACCESS Newswire
Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date
October 29, 2025
Via
ACCESS Newswire
Revelation Biosciences Inc. Announces Adjournment of October 15, 2025 Special Meeting of Stockholders to October 29, 2025
October 15, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
September 11, 2025
Via
Benzinga
Revelation Biosciences Inc. Announces Exercise of Warrants for $9.6 Million in Gross Proceeds
September 11, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
September 10, 2025
Via
Benzinga
Revelation Biosciences Announces Special Webcast to Review Positive Top-line Clinical Data
September 10, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
September 09, 2025
Via
Benzinga
Reminder - Webcast/Conference Call to Discuss Fantastic PRIME Phase 1b Top-line Data
September 09, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
September 09, 2025
Via
Benzinga
Revelation Biosciences Announces Groundbreaking Top-line Results from PRIME Clinical Study
September 09, 2025
Via
ACCESS Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
